Cargando…
Duchenne muscular dystophy: A short review and treatment update
After advances in clinical care and newer efforts in therapeutic approaches, life span has lengthened in Duchenne muscular dystrophy (DMD). Starting from eary 1980s, each decade lead to a five year gain. DMD is not simply a monogenic X-linked disorder, it is a multisystemic condition. Pulmonary, car...
Autor principal: | TOPALOGLU, Haluk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376018/ https://www.ncbi.nlm.nih.gov/pubmed/36213153 http://dx.doi.org/10.22037/ijcn.v16i1.33282 |
Ejemplares similares
-
Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy
por: Eser, Gökçe, et al.
Publicado: (2022) -
Joining mainstream research on Facioscapulohumeral Dystophy: disease prevalence in China
por: Magdinier, Frédérique
Publicado: (2021) -
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020) -
Ultrasonographic assessment of lower limb muscle architecture in children with early-stage Duchenne muscular dystrophy
por: BULUT, Numan, et al.
Publicado: (2022) -
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
por: Crisafulli, Salvatore, et al.
Publicado: (2020)